Bénéfices
| Q1 2024 | Évaluation | Réelle | Surprise |
|---|---|---|---|
| BPA: | 0.320 | ||
| Révision: | $318.96M | $392.60M | — |
| Q4 2023 | Évaluation | Réelle | Surprise |
|---|---|---|---|
| BPA: | -0.190 | 0.210 | 0.4000 |
| Révision: | $332.30M | $383.60M | $39.40M |
| Q3 2023 | Évaluation | Réelle | Surprise |
|---|---|---|---|
| BPA: | 1.210 | 1.210 | 0.0000 |
| Révision: | $464.28M | $482.00M | -$18.28M |
| Q2 2023 | Évaluation | Réelle | Surprise |
|---|---|---|---|
| BPA: | 1.370 | 1.410 | 0.0400 |
| Révision: | $486.43M | $419.90M | -$4.63M |
